IQVIA™ Real-World Insights Bibliography

Long-Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity.
Author(s): Alberto Esquenazi 1, Ganesh Bavikatte 2, Daniel S Bandari 3, Wolfgang H Jost 4 5, Michael C Munin 6, Simon Fuk Tan Tang 7, Joan Largent 8, Aubrey Manack Adams 9, Aleksej Zuzek 9, Gerard E Francisco 10
Affiliations(s): 1MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA. 2The Walton Centre, Liverpool, UK. 3Multiple Sclerosis Center of California, Laguna Hills, CA, USA. 4Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany. 5Parkinson-Klinik Ortenau, Wolfach, Germany. 6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 7Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan. 8IQVIA Real-World Evidence Solutions, Cambridge, MA, USA. 9Allergan, An AbbVie company, Irvine, CA, USA. 10University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA.
Publication(s):  PMID: 33151636 DOI: 10.1002/pmrj.12517
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Neurological disorders,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Protocol of the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy
Author(s): Udeh-Momoh CT, Watermeyer T, Price G, de Jager Loots CA, Reglinska-Matveyev N, Ropacki M, Ketter N, Fogle M, Raghavan N, Arrighi M, Brashear R, Di J, Baker S, Giannakopoulou P, Robb C, Bassil D, Cohn M, McLellan-Young H, Crispin J, Lakey K, Lisa C, Chowdary Seemulamoodi Y, Kafetsouli D, Perera D, Car J, Majeed A, Ward H, Ritchie K, Perneczky R, Kivipelto M, Scott D, Bracoud L, Saad Z, Novak G, Ritchie CW, Middleton L
Affiliations(s): Imperial College London
Publication(s):  BMJ Open
Document Type(s): Article,
Countries: UK,
Click here for the abstract
C:
Y:
Neurological disorders,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden
Author(s): Meritxell Sabidó1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5
Affiliations(s): 1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA
Publication(s):  ECTRIMS 2021, Digital, 13-15 October 2021
Document Type(s): Abstract,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Drug Utlization Study, Neurological disorders,
2021
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden
Author(s): Meritxell Sabidó1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5
Affiliations(s): 1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA
Publication(s):  ECTRIMS 2021, Digital, 13-15 October 2021
Document Type(s): Poster,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Drug Utlization Study, Neurological disorders,
2021
  L:
A:
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Infections in patients with multiple sclerosis: A national cohort study in Sweden
Author(s): Anna Castelo-Branco, Flaminia Chiesa, Simona Conte, Camilla Bengtsson , Sally Lee, Neil Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations(s): 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publication(s):  Mult Scler Relat Disord. 2020;45:102420. [published online ahead of print, 2020 Jul 23].
Document Type(s): Abstract,
Countries: Sweden,
Click here for the abstract
C:
Y:
Infectious disease, Neurological disorders, Patient Registries & Real-World Study Methods,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden
Author(s): Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson , Sally Lee, Neil N Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations(s): 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publication(s):  Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3): 2055217320947761. Published online 2020 Aug 14
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Cardiovascular disease, Neurological disorders, Patient Registries & Real-World Study Methods,
2020
  L:
A:
English
Epidemiological study, Observational study, Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
Author(s): Gerard E Francisco 1, Daniel S Bandari 2, Ganesh Bavikatte 3, Wolfgang H Jost 4 5, Emily McCusker 6, Joan Largent 7, Aleksej Zuzek 6, Alberto Esquenazi 8
Affiliations(s): 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX, USA. 2Multiple Sclerosis Center of California & Research Group, Newport Beach, CA, USA. 3The Walton Centre, Liverpool, UK. 4University of Freiburg, Department of Neurology, Freiburg im Breisgau, Germany. 5Parkinson-Klinik Ortenau, Wolfach, Germany. 6Allergan, an AbbVie Company, Irvine, CA, USA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA, USA. 8MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, USA.
Publication(s):  PMID: 32875289 PMCID: PMC7452133 DOI: 10.1016/j.toxcx.2020.100040
Document Type(s): Article,
Countries: Europe, USA,
Click here for the abstract
C:
Y:
Neurological disorders,
2020
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician- and Patient-Reported Satisfaction: Long-Term Observational Results from the ASPIRE Study
Author(s): Gerard E Francisco 1, Wolfgang H Jost 2, Ganesh Bavikatte 3, Daniel S Bandari 4, Simon F T Tang 5, Michael C Munin 6, Joan Largent 7, Aubrey M Adams 8, Aleksej Zuzek 8, Alberto Esquenazi 9
Affiliations(s): 1The University of Texas Health Science Center McGovern Medical School and TIRR Memorial Hermann, Houston, TX. 2Department of Neurology, University of Freiburg, Freiburg im Breisgau, Germany. 3The Walton Centre, Liverpool, UK. 4Multiple Sclerosis Center of California & Research Group, Newport Beach, CA. 5Department of Physical Medicine and Rehabilitation, Lotung Poh-Ai Hospital, Yilan, Taiwan. 6Department of Physical Medicine and Rehabilitation, University of Pittsburgh School of Medicine, Pittsburgh, PA. 7IQVIA Real-World Evidence Solutions, Cambridge, MA. 8Allergan plc, Irvine, CA. 9MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA.
Publication(s):  PMID: 31953896 PMCID: PMC7687094 DOI: 10.1002/pmrj.12328
Document Type(s): Article,
Countries: Asia Pacific, Europe, USA,
Click here for the abstract
C:
Y:
Neurological disorders,
2020
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Multicenter Prospective Evaluation of Parenteral Nutrition Preparation Time and Resource Utilization: 3-Chamber Bags Compared With Hospital Pharmacy-Compounded Bags
Author(s): Sarah V Cogle 1 2, Robert G Martindale 3, Mafalda Ramos 4, Gregory J Roberti 5, Pamela R Roberts 6, Kaci Taylor 7, Gordon S Sacks 1 8
Affiliations(s): 1Department of Pharmacy Practice, Auburn University, Auburn, Alabama, USA. 2Department of Pharmacy, East Alabama Medical Center, Opelika, Alabama, USA. 3Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA. 4IQVIA, Zaventem, Belgium. 5Department of Pharmacy, Oregon Health and Science University, Portland, Oregon, USA. 6Department of Anesthesiology, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, USA. 7Department of Pharmacy, OU Medical Center, Oklahoma City, Oklahoma, USA. 8Medical Affairs, Fresenius Kabi, LLC, Lake Zurich, Illinois, USA.
Publication(s):  Journal of Parenteral and Enteral Nutrition Volume 0 Number 0 November 2020 1?7 DOI: 10.1002/jpen.2045
PMID: 33188572 DOI: 10.1002/jpen.2045
Document Type(s): 
Countries: USA,
Click here for the abstract
C:
Y:
Health economics, Neurological disorders,
2020
  L:
A:
English
Clinical setting: hospital, Cost effectiveness, Prospective study,
  Add to report
 
 
The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis
Author(s): Freedman MS1, Duquette P2, Grand'Maison F3, Lee L4, Vorobeychik G5, Lara N6, Khurana V7, Nakhaipour HR8, Schecter R8, Haddad P8
Affiliations(s): 1 University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2 Notre Dame Hospital, Université de Montréal, Montreal, Quebec , Canada 3 Neuro-Rive Sud Clinic , Greenfield Park , Quebec , Canada 4 Sunnybrook Health Sciences Centre , University of Toronto , Toronto , Ontario , Canada 5 Fraser Health Multiple Sclerosis Clinic Burnaby Hospital , Burnaby , British Columbia , Canada 6 IQVIA , Barcelona , Spain 7 Novartis Healthcare Private Limited , Hyderabad , India 8 Novartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada
Publication(s):  Curr Med Res Opin. 2019 May;35(5):767-776
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Burden of illness, Retrospective Field Study,
  Add to report
 
 
 1 of 22 Next Page Last Page